In PALB2-associated breast cancers, the accompanying mutations included germline BRCA1 mutation and somatic TP53, PIK3CA, PALB2, ERBB3, and RB1 mutations (Tables 1, 3). This evidence concerns the gene TP53 and breast carcinoma.